HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The ocular pathology of Norrie disease in a fetus of 11 weeks' gestational age.

Abstract
The ocular pathology of Norrie disease was studied for the first time in a fetus of 11 weeks' gestation, following prenatal diagnosis using genetic markers for Norrie disease and elective abortion. The eyes were histologically normal, with no evidence of primary neuroectodermal maldevelopment of the retina, previously postulated to be the cause of the ocular changes. We believe that the retinal and other manifestations of Norrie disease are the result of a primary abnormality of vascular proliferation, probably in relation to persistent hyperplastic primary vitreous after approximately 14 weeks' gestation. We postulate that the ocular and otological effects of Norrie disease may be due to a genetically mediated abnormality of secretion of, or sensitivity to, angiogenic growth factors at endodermal-neuroectodermal interfaces during fetal and postnatal development.
AuthorsM A Parsons, D Curtis, C E Blank, H N Hughes, A C McCartney
JournalGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (Graefes Arch Clin Exp Ophthalmol) Vol. 230 Issue 3 Pg. 248-51 ( 1992) ISSN: 0721-832X [Print] Germany
PMID1350768 (Publication Type: Case Reports, Journal Article)
Chemical References
  • DNA Probes
Topics
  • Abortion, Legal
  • Adult
  • Blindness (embryology, pathology)
  • DNA Probes
  • Deafness (embryology)
  • Eye (embryology, pathology)
  • Female
  • Fetal Diseases (genetics, pathology)
  • Fetus
  • Genetic Linkage
  • Gestational Age
  • Humans
  • Male
  • Polymorphism, Restriction Fragment Length
  • Prenatal Diagnosis
  • Retina (abnormalities, embryology)
  • X Chromosome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: